SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008072
Filing Date
2018-10-30
Accepted
2018-10-30 16:31:46
Documents
68
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20180930x10q.htm 10-Q 1835615
2 EX-31.1 bpmc-20180930ex311934351.htm EX-31.1 18202
3 EX-31.2 bpmc-20180930ex3128569fb.htm EX-31.2 18257
4 EX-32.1 bpmc-20180930ex32120df80.htm EX-32.1 13874
  Complete submission text file 0001558370-18-008072.txt   6637607

Data Files

Seq Description Document Type Size
5 EX-101.INS bpmc-20180930.xml EX-101.INS 1420432
6 EX-101.SCH bpmc-20180930.xsd EX-101.SCH 52942
7 EX-101.CAL bpmc-20180930_cal.xml EX-101.CAL 46865
8 EX-101.DEF bpmc-20180930_def.xml EX-101.DEF 165837
9 EX-101.LAB bpmc-20180930_lab.xml EX-101.LAB 423698
10 EX-101.PRE bpmc-20180930_pre.xml EX-101.PRE 331552
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 181147328
SIC: 2834 Pharmaceutical Preparations